Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue

Authors:

Abstract
Bone‐marrow mesenchymal stem cells (MSCs) are the origin of bone‐forming cells with immunomodulation potential. HLA‐G5 is among the generated immunosuppressive molecules. HLA‐G proteins play a crucial role in promoting the acceptance of allografts. However, the mechanisms regulating the expression of HLA‐G5 in human MSCs are unknown. We induced differentiation of MSCs and found that HLA‐G5 was greatly up‐regulated only in osteoblastic cells (+63% for mRNA). Growth plates and bone callus postfracture in adults showed that only bone‐lining cells and mesenchymal progenitors were positive for HLA‐G5. Use of gene silencing and dominant‐negative factors revealed that HLA‐G5 depends on the expression and function of the skeletogenesis master genes RUNX2 and DLX5. In addition, HLA‐G5 could directly inhibit osteoclastogenesis by acting on monocytes through SHP1. However, in mature osteoblasts, the expression of HLA‐G5 protein was greatly suppressed whereas the proosteoclastogenic factor, RANKL, was concomitantly increased. Down‐regulation of HLA‐G5 expression during the maturation of osteoblasts was due to binding of the repressor GLI3, a signal transducer of the Hedgehog pathway, to the GLI binding element within the HLA‐G promoter. Our findings show that mesenchymal progenitors and osteoblastic cells specifically express HLA‐G5 during osteogenesis, with a key role in bone homeostasis.—Deschaseaux, F., Gaillard, J., Langonné, A., Chauveau, C., Naji, A., Bouacida, A., Rosset, P., Heymann, D., De Pinieux, G., Rouas‐Freiss, N., Sensébé, L., Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue. FASEB J. 27, 2977–2987 (2013). www.fasebj.org

This publication has 38 references indexed in Scilit: